Fibroblast Activation Protein as a Molecular Handle in Cancer Phototheranostics: Recent Advances
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c00482 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Sangramjit Basak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, National Institute of Pharmaceutical Education and Research, Raebareli, Lucknow, UP 226002, India. Hauptthemen laut MEDLINE: Neoplasms, Serine Endopeptidases, Gelatinases, Membrane Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Institute of Pharmaceutical Education and Research, Raebareli, Department of Science and Technology, Ministry of Science and Technology, India, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India.
Abstract (Originalsprache)
Fibroblast activation protein (FAP) is a type II transmembrane serine protease that is selectively overexpressed in the tumor microenvironment (TME) of various cancer phenotypes, making it a promising target for personalized cancer therapy. Unlike other broadly expressed surface proteins, FAP is predominantly found in cancer-associated fibroblasts (CAFs), where it plays a crucial role in tumor progression. This selective expression enables targeted therapeutic interventions with minimal off-target toxicity. Conventional and some advanced cancer treatment modalities are often associated with significant background toxicity, which can be mitigated by secondary treatment strategies such as phototherapy. This review provides a comprehensive overview of the latest developments in FAP-targeted phototheranostic probes, including small molecules, peptides, and antibodies. Special emphasis is given to advancements in near-infrared (NIR)-based phototherapeutic probes, highlighting their improved imaging and therapeutic efficacy through enhanced tissue penetration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, National Institute of Pharmaceutical Education and Research, Raebareli, Lucknow, UP 226002, India.
ORCID-Profile: Niranjan Meher
Förderung
- National Institute of Pharmaceutical Education and Research, Raebareli
- Department of Science and Technology, Ministry of Science and Technology, India
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India
Zitieren
APA
Basak, S., Satapathy, S., Shukla, A., Srivastava, N., & Meher, N. (2025). Fibroblast Activation Protein as a Molecular Handle in Cancer Phototheranostics: Recent Advances. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00482
Vancouver
Basak S, Satapathy S, Shukla A, Srivastava N, Meher N. Fibroblast Activation Protein as a Molecular Handle in Cancer Phototheranostics: Recent Advances. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00482
BibTeX
@article{Basak2025,
author = {Basak, Sangramjit and Satapathy, Subhadarshini and Shukla, Anitya and Srivastava, Nidhi and Meher, Niranjan},
title = {Fibroblast Activation Protein as a Molecular Handle in Cancer Phototheranostics: Recent Advances},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c00482}
}
EUVIMED